Bio-Rad Laboratories (BIO) Current Leases (2019 - 2026)

Bio-Rad Laboratories (BIO) has reported Current Leases for 8 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases fell 14.5% year-over-year to $33.6 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 14.5% decrease from a year earlier, with the FY2025 full-year figure at $36.1 million, down 13.43% from the prior year.
• Current Leases was $33.6 million for Q2 2026 at Bio-Rad Laboratories, down from $36.2 million in the prior quarter.
• Over five years, Current Leases peaked at $42.8 million in Q3 2024 and troughed at $33.6 million in Q2 2026.
• A 5-year average of $38.0 million and a median of $36.8 million in 2022 frame the typical range for Current Leases.
• Across the five-year window, Current Leases grew 14.9% in 2023 and decreased 14.5% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $36.3 million in 2022, then advanced by 11.18% to $40.4 million in 2023, then increased by 3.22% to $41.7 million in 2024, then retreated by 13.43% to $36.1 million in 2025, then dropped by 6.93% to $33.6 million in 2026.
• The last three Current Leases figures came in at $33.6 million (Q2 2026), $36.2 million (Q1 2026), and $36.1 million (Q4 2025), per Business Quant data.